The emergency use authorization (EUA) for a traditional herbal formula developed in Taiwan to treat COVID-19, known as Taiwan Chingguan Yihau (NRICM101), will be extended to June 2024, Health Minister Hsueh Jui-yuan (薛瑞元) said Sunday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
Taiwan to shorten COVID-19 vaccine interval to 2 months for high-risk groupsThe Centers for Disease Control (CDC) announced Thursday that the required interval between two COVID-19 vaccine doses for high-risk groups will be shortened from six months to two months, effective next Wednesday.06/06/2025 08:17 PM
CDC confirms ample supply of COVID-19 drugs, vaccinesThe Centers for Disease Control (CDC) reiterated Sunday that Taiwan has sufficient antiviral medication for COVID-19 patients and emphasized the importance of vaccination, amid concerns raised by public figures.06/01/2025 06:13 PM
CDC issues COVID-19 warning as Dragon Boat Festival long weekend beginsMembers of the public should not let their guard down on COVID-19 and seek medical help if they experience symptoms that indicate risk of severe infection, the Centers for Disease Control (CDC) said Friday, the first day of the Dragon Boat Festival long weekend in Taiwan.05/30/2025 05:04 PM
Latest
- Business
Taiwan, Czech institutes launch African medical aid procurement program
12/04/2025 07:25 PM - Politics
Taiwan to ban food-waste pig feeding from 2027, with 1-year transition
12/04/2025 06:39 PM - Business
Taiwan and India to build 'resilient' supply chain: MOEA
12/04/2025 05:47 PM - Society
Space weather disturbance may disrupt satellite, radio communications
12/04/2025 05:45 PM - Science & Tech
Tokyo Electron vows to tighten compliance after Taiwan unit indicted
12/04/2025 04:03 PM


